PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial

BACKGROUND: In kidney transplantation, the use of Anti-Thymocyte Globulins (ATG) as induction therapy has been described as a possible treatment for reducing the prevalence of Delayed Graft Function (DGF). ATG possesses pharmaceutical proprieties that could help control the lesions caused by ischemi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Chapal, Marion, Foucher, Yohann, Marguerite, Monique, Neau, Karine, Papuchon, Emmanuelle, Daguin, Pascal, Morélon, Emmanuel, Mourad, Georges, Cassuto, Elisabeth, Ladrière, Marc, Legendre, Christophe, Giral, Magali
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477597/
https://ncbi.nlm.nih.gov/pubmed/26099226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0807-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars